Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD69 | Q07108 | 1/20 | 0.51 |
| ▸ | AMY2A | P04746 | 4/20 | 0.49 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.48 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.48 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.44 |
| ▸ | CHIA | Q9BZP6 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8744664 | 1.00 | CD69 (0.51) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744598 | 1.00 | CD69 (0.51) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744603 | 1.00 | CD69 (0.51) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL9463707 | 0.95 | CD69 (0.55) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL9463703 | 0.95 | CD69 (0.55) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744649 | 0.93 | CD69 (0.48) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744644 | 0.93 | CD69 (0.48) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744596 | 0.91 | LGALS3 (0.47) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL8744558 | 0.91 | LGALS3 (0.47) | CD69AMY2ALGALS3LGALS8LGALS4 | |
| SCHEMBL30876544 | 0.91 | LGALS3 (0.51) | CD69AMY2ALGALS3LGALS8LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0593419-B1 | INHIBITORS FOR GLYCOSAMINOSYL TRANSFERASE-V | ALBERTA RES COUNCIL (CA) | 1997-01-22 | — | — | EP | disclosed |
| US-5206356-A | Therapy and diagnosis of metastatic metabolic states | CHEMBIOMED, LTD. (CA) | 1993-04-27 | — | — | US | disclosed |
| US-5032505-A | Enzyme inhibitors | CHEMBIOMED, LTD. (CA) | 1991-07-16 | — | — | US | disclosed |